At the request of the U.S. Food and Drug Administration (FDA), Abbott is releasing limited quantities of metabolic nutrition formulas that were previously on hold following Abbott's recall of some powder infant formulas from its Sturgis, Mich., facility. The products have been tested and comply with all product release requirements before distribution. The lots being released were not included in the recall.

These products are used under the care of a healthcare professional and require a medical referral. Patients, caregivers and healthcare professionals in need of these products should contact Abbott at +1-800-881-0876 to provide necessary information. Abbott will work with metabolic centers and healthcare providers to fulfill requests based on need and on a case-by-case basis.

The metabolic products being released are: Calcilo XD®; Cyclinex®-1 and 2; Glutarex®-1 and 2; Hominex®-1 and 2; I-Valex®-1 and 2; Ketonex®-1 and 2; Phenex®-1 and 2; Pro-Phree®; Propimex®-1 and 2; ProViMin®; and Tyrex®-1 and 2. The specialty product being released is: Similac® PM 60/40. Similac®, Alimentum® and EleCare® powder formulas that were voluntarily recalled in February are not included in this product release. Abbott has limited inventory of these products.

New product is not currently being manufactured. Abbott has implemented corrective actions and is working with the FDA to address the situation before resuming operations at the Sturgis facility. Once Abbott resumes production, it will take at least six to eight weeks for product to be available for distribution.